Dell's Michael Dell discusses the 'Trump Account' that's a part of Congress' latest budget bill.

image for news Dell CEO on 'Trump Account': Dell will match government contributions for children born to employees

Apple Unveils Liquid Glass Operating System at WWDC — Positive

AAPL   Bloomberg Markets and Finance — June 09, 2025

Apple Inc. unveiled a new operating system interface called Liquid Glass at its annual Worldwide Developers Conference, an event that focused heavily on aesthetics and design elements rather than software breakthroughs. Bloomberg's Ed Ludlow was there and reports.

image for news Apple Unveils Liquid Glass Operating System at WWDC

Legendary American design icons blend signature engineering and architectural styles JACKSON CENTER, Ohio , June 9, 2025 /PRNewswire/ -- Airstream® , the iconic manufacturer of world-class recreational vehicles, and the Frank Lloyd Wright Foundation have partnered to debut the Airstream Frank Lloyd Wright Usonian Limited Edition Travel Trailer. A tribute to American design and organic architecture, the limited-edition travel trailer personifies Frank Lloyd Wright's unmatched architectural vision and Airstream Founder Wally Byam's innovative approach to mobile living and the pursuit of travel freedom.

image for news Airstream and Frank Lloyd Wright Foundation Launch Limited Edition Travel Trailer

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE:ELV) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Elevance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/elevance-health-inc.

image for news ELV LEGAL UPDATE: A Class Action was filed on behalf of Elevance Health, Inc. Shareholders - Contact BFA Law by the July 11 Deadline

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ:FTRE) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit.

image for news FTRE LEGAL UPDATE: A Class Action was filed on behalf of Fortrea Holdings Inc. Shareholders - Contact BFA Law by the August 1 Deadline

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Iovance you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/iovance-biotherapeutics-inc-class-action-lawsuit.

image for news IOVA LEGAL UPDATE: A Class Action was filed on behalf of Iovance Biotherapeutics, Inc. Shareholders - Contact BFA Law by the July 14 Deadline

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against UroGen Pharma Ltd. (NASDAQ:URGN) and certain of the Company's senior executives for potential violations of the federal securities laws.

image for news URGN LEGAL UPDATE: A Class Action Was Filed on Behalf of UroGen Pharma Ltd. Shareholders - Contact BFA Law by The July 28 Deadline

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Compass Diversified Holdings and Compass Group Diversified Holdings, LLC (NYSE:CODI) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Compass you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/compass-diversified-holdings.

image for news CODI LEGAL UPDATE: A Class Action Was Filed on Behalf of Compass Diversified Holdings Shareholders - Contact BFA Law by The July 8 Deadline

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Civitas Resources, Inc. (NYSE:CIVI) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Civitas you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/civitas-resources-inc.

image for news CIVI LEGAL UPDATE: A Class Action was filed on behalf of Civitas Resources, Inc. Shareholders - Contact BFA Law by the July 1 Deadline

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Reddit, Inc. (NYSE:RDDT) for potential violations of the federal securities laws. If you invested in Reddit, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/reddit-inc-securities-fraud-class-action.

image for news RDDT LEGAL UPDATE: A Securities Fraud Investigation Has Been Initiated on Behalf of Reddit, Inc. Shareholders - Contact BFA Law

NEW YORK CITY, NY / ACCESS Newswire / June 9, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Organon & Co. (NYSE:OGN) and certain of the Company's senior executives for potential violations of the federal securities laws. If you invested in Organon you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/organon-co-class-action.

image for news OGN LEGAL UPDATE: A Class Action was filed on behalf of Organon & Co. Shareholders - Contact BFA Law by the July 22 Deadline

The Food and Drug Administration approved Merck's shot designed to protect infants from respiratory syncytial virus during their first season of the virus. The decision will allow the company to launch the drug, which will be marketed as Enflonsia, ahead of the RSV season that typically kicks off around fall and winter.

image for news FDA approves Merck's RSV shot for infants, ramping up competition with Sanofi and AstaZeneca

NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your Civitas Resources, Inc. (NYSE:CIVI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/civitas-resources-lawsuit-submission-form?prid=152321&wire=1&utm_campaign=13 or contact Joseph E. Levi, Esq.

image for news Securities Class Action Lawsuit Filed Against Civitas Resources, Inc. (CIVI) - Levi & Korsinsky Represents Shareholders

IRVINE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- MUSE Microscopy, Inc., a pioneer in digital pathology innovation, today announced the formation of MUSE Veterinary Digital Pathology , LLC, a wholly-owned subsidiary focused on transforming pathology through point-of-care service. This initiative aims to provide same-day results for tissue biopsies. This new service will provide the gold standard of patient care allowing veterinarians to deliver pet parents with diagnosis, prognosis, and treatment plans efficiently using the SmartPath MUSE Technology™ (SmartPath)* Platform.

image for news MUSE Microscopy, Inc. Launches Veterinary Digital Pathology with the First-of-Its-Kind Tissue-to-Direct Digital Imaging for the Veterinary Market

Science Applications International Is a Wicked Hot Buy in June — Negative

SAIC   MarketBeat — June 09, 2025

Science Applications International's NYSE: SAIC share price imploded following Donald Trump's election to the U.S. Presidency and is now offering a screaming hot entry for investors.

image for news Science Applications International Is a Wicked Hot Buy in June

eToro Group Ltd (NASDAQ:ETOR) has been given a ‘Neutral' rating and a 12-month price target of $70, reflecting modest upside, in initial coverage from analysts at UBS. The bank's analysts view eToro as a key beneficiary of the surge in global retail investor activity, particularly outside the United States.

image for news eToro rated ‘Neutral' in initial coverage as execution, volatility remain key risks

BOSTON, MA / ACCESS Newswire / June 9, 2025 / Block & Leviton is investigating Abacus Global Management, Inc. (NASDAQ:ABL) for potential securities law violations. Investors who have lost money in their Abacus Global Management, Inc. investment should contact the firm to learn more about how they might recover those losses.

image for news Abacus Global Management Investors May Be Able to Recover Losses By Contacting Block & Leviton LLP

NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your Organon & Co. (NYSE:OGN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/organon-co-lawsuit-submission-form?prid=152319&wire=1&utm_campaign=21 or contact Joseph E. Levi, Esq.

image for news Shareholders of Organon & Co. (OGN): Protect Your Rights Before July 22, 2025 - Contact Levi & Korsinsky

NEW YORK, NY / ACCESS Newswire / June 9, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=152320&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

image for news Levi & Korsinsky Urges West Pharmaceutical Services, Inc. (WST) Shareholders to Act Before Lead Plaintiff Deadline July 7, 2025

Significant Withhold Votes from Directors Mary Ann Gray and Alpna Seth Underscores Need for Change and a More Disciplined Capital Allocation Strategy AUSTIN, Texas , June 9, 2025 /PRNewswire/ -- ADAR1 Capital Management, LLC (together with its affiliates, "ADAR1" or "We"), the largest stockholder of Keros Therapeutics (Nasdaq: KROS) ("Keros" or the "Company"), today issued the following statement regarding the results of the Company's 2025 Annual Meeting of Stockholders (the "Annual Meeting"): "We believe the outcome of the Annual Meeting underscores what we have consistently conveyed to Keros' Board of Directors: there is broad and growing concern among stockholders regarding …

image for news ADAR1 Issues Statement on Keros Therapeutics' Troubling 2025 Director Election Results and Insufficient Capital Return Proposal